ZYMEWORKS INC. Operating Cash Flow
ZYMEWORKS INC. (ZYME) reported Operating Cash Flow of -$77.67 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- ZYMEWORKS INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$31.95M, a 364.62% decline year-over-year.
- ZYMEWORKS INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$45.72M.
- ZYMEWORKS INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$10.26M.
- ZYMEWORKS INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$31.41M.
- ZYMEWORKS INC. net cash provided by (used in) operating activities for fiscal 2025 was -$33.01M.
- ZYMEWORKS INC. net cash provided by (used in) operating activities for fiscal 2024 was -$110.06M.
- ZYMEWORKS INC. net cash provided by (used in) operating activities for fiscal 2023 was -$118.32M, a 182.11% decline from fiscal 2022.
- ZYMEWORKS INC. net cash provided by (used in) operating activities for fiscal 2022 was $144.11M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$31.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$77.67M 10-Q · filed 2026-08-06 | -$87.92M derived: sum of 3 quarters · filed 2026-08-06 | -$119.34M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$45.72M 10-Q · filed 2026-05-07 | -$55.98M derived: sum of 2 quarters · filed 2026-05-07 | -$87.39M derived: sum of 3 quarters · filed 2026-05-07 | -$75.32M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$10.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$41.67M derived: sum of 2 quarters · filed 2026-03-02 | -$29.60M derived: sum of 3 quarters · filed 2026-08-06 | -$33.01M 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | -$31.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$19.34M derived: sum of 2 quarters · filed 2026-08-06 | -$22.75M 10-Q · filed 2025-11-06 | -$64.26M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $12.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $8.67M 10-Q · filed 2026-08-06 | -$32.84M derived: sum of 3 quarters · filed 2026-08-06 | -$38.72M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$3.41M 10-Q · filed 2026-05-07 | -$44.92M derived: sum of 2 quarters · filed 2026-05-07 | -$50.80M derived: sum of 3 quarters · filed 2026-05-07 | -$75.79M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$41.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$47.39M derived: sum of 2 quarters · filed 2026-03-02 | -$72.38M derived: sum of 3 quarters · filed 2026-03-02 | -$110.06M 10-K · filed 2026-03-02 | -$110.04M 10-K · filed 2025-03-05 | |||
| 2024-09-30 | -$5.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$30.87M derived: sum of 2 quarters · filed 2025-11-06 | -$68.55M 10-Q · filed 2025-11-06 | -$68.54M 10-Q · filed 2024-10-31 | -$54.62M derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2024-06-30 | -$24.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$62.67M 10-Q · filed 2025-08-07 | -$62.66M 10-Q · filed 2024-08-01 | -$48.73M derived: sum of 3 quarters · filed 2026-03-02 | -$91.40M derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2024-03-31 | -$37.67M 10-Q · filed 2025-05-08 | -$37.67M 10-Q · filed 2024-05-02 | -$23.74M derived: sum of 2 quarters · filed 2026-03-02 | -$66.41M derived: sum of 3 quarters · filed 2026-03-02 | -$72.81M derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2023-12-31 | $13.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$28.73M derived: sum of 2 quarters · filed 2026-03-02 | -$35.13M derived: sum of 3 quarters · filed 2026-03-02 | -$118.32M 10-K · filed 2026-03-02 | -$118.30M 10-K · filed 2024-03-06 | |||
| 2023-09-30 | -$42.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$49.07M derived: sum of 2 quarters · filed 2024-10-31 | -$132.26M 10-Q · filed 2024-10-31 | $195.10M derived: sum of 4 quarters · filed 2025-03-05 | ||||
| 2023-06-30 | -$6.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$89.59M 10-Q · filed 2024-08-01 | $237.77M derived: sum of 3 quarters · filed 2025-03-05 | $164.75M derived: sum of 4 quarters · filed 2025-03-05 | ||||
| 2023-03-31 | -$83.19M 10-Q · filed 2024-05-02 | $244.17M derived: sum of 2 quarters · filed 2025-03-05 | $171.15M derived: sum of 3 quarters · filed 2025-03-05 | $116.33M derived: sum of 4 quarters · filed 2025-03-05 | ||||
| 2022-12-31 | $327.36M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $254.34M derived: sum of 2 quarters · filed 2025-03-05 | $199.52M derived: sum of 3 quarters · filed 2025-03-05 | $144.11M 10-K · filed 2025-03-05 | ||||
| 2022-09-30 | -$73.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$127.84M derived: sum of 2 quarters · filed 2023-11-07 | -$183.25M 10-Q · filed 2023-11-07 | -$233.76M derived: sum of 4 quarters · filed 2024-03-06 | ||||
| 2022-06-30 | -$54.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$110.24M 10-Q · filed 2023-08-10 | -$160.75M derived: sum of 3 quarters · filed 2024-03-06 | |||||
| 2022-03-31 | -$55.41M 10-Q · filed 2023-05-08 | -$105.92M derived: sum of 2 quarters · filed 2024-03-06 | ||||||
| 2021-12-31 | -$50.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | -$192.45M 10-K · filed 2024-03-06 | ||||||
| 2021-09-30 | -$141.94M 10-Q · filed 2022-11-08 | |||||||
| 2020-12-31 | -$151.40M 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |